Thorsten Gutjahr

VP, Global Head of Companion Diagnostics, AstraZeneca
When
13th-14th Sep 2018
Where
Munich, Germany
Holiday Inn Munich
Following our very successful 2017 meeting, the 5th Precision Medicine & Biomarkers Leaders Summit: Europe which is confirmed to take place on September 13-14, 2018 in Munich, Germany. The 2018 summit will provide a forum to network, learn and engage with senior representatives of leading pharmaceutical and biotech companies worldwide.
This year’s the meeting will continue to provide an exceptional forum to network, learn and engage with senior representatives of leading pharmaceutical and biotech companies worldwide. As an attendee, you have a unique opportunity to mix and interact with experts working in all facets of Precision Medicine through the purposely designed agenda which includes individual, panel and roundtable discussions. Four separate tracks featuring the latest research on the strategies and technology required to facilitate Precision Medicine; Biomarkers; Diagnostics and immuno-oncology will attract 175 attendees.
CEO, InnVentis
Assay Development & Validation Manager, Almac Diagnostics
Senior Director – Translational Research, Crohn’s & Colitis Foundation
Vice President, Global Pricing & Market Access, Galapagos NV
Sr. Marketing Manager, EMEA, Fluidigm Corporation
Senior Lecturer (Associate Professor) and Group Leader in Applied Cancer Immunopathology, Systems Cancer Immunology Lab, Guy’s Hospital, London, UK
Senior Manager, Applications for Immuno-oncology and Vaccines, JSR Micro, Life Sciences and MBLI
Global Product and Innovation Manager – BOND RX, Leica Biosystems
Director, Customer Engagement, Ultivue
PHC Partnering Director, Roche Diagnostics GmbH
CTO, Turbine
Commercial Director, Oncimmune
Director GOBIOM Biomarker and Biology Services, Excelra
CTO, Insilico Medicine
Research Lecturer in Cancer Biology, PI Cancer Niche Group, Director of Blood Cancer Biobank Ireland, National University of Ireland, Galway
Director, Max Plank Institute for Molecular Genetics
Head of Diagnostics, LifeArc
Associate Principal Scientist, Science and Enabling Units IT, AstraZeneca
Senior Manager Global Regulatory Affairs, Biomarkers and Diagnostics, Merck KGaA
Director, Scientific Marketing, Metabolon
CEO, Intomics A/S
Professor of Medicine, Mayo Clinic
Co-founder and CEO, Data4Cure
Founder and CEO, Vibrent Health Inc., Principal Investigator (PI), Participant Technology Systems Center (PTSC), Co-Chair, Data Privacy and Security Work Group, Precision Medicine Initiative National Institutes of Health (NIH)
Co-founder and CEO, Pangea Diagnostics
Global Product General Manager, Early Development, Amgen, Inc
Institute of Genomics, Head of the Estonian Biobank, University of Tartu
VP, Global Head of Companion Diagnostics, AstraZeneca
Director of Business Development, Abcam
Director, Precision Medicine Policy and Business Insights, AstraZeneca
Commercial Programme Delivery Lead, Genomics England
Head of Biomarkers, Diagnostics and Assay Development, Turnstone Biologics
Director, Immunology Translational Medicine, UCB
Head Translational and Clinical Projects, Helmholtz Zentrum München
Senior Scientist Clinical Biomarker Biobanking, Merck KGaA
Senior Principal Scientist, Translational Sciences, Sanofi France
CEO, InnVentis
Assay Development & Validation Manager, Almac Diagnostics
Senior Director – Translational Research, Crohn’s & Colitis Foundation
Vice President, Global Pricing & Market Access, Galapagos NV
Sr. Marketing Manager, EMEA, Fluidigm Corporation
Senior Lecturer (Associate Professor) and Group Leader in Applied Cancer Immunopathology, Systems Cancer Immunology Lab, Guy’s Hospital, London, UK
Senior Manager, Applications for Immuno-oncology and Vaccines, JSR Micro, Life Sciences and MBLI
Global Product and Innovation Manager – BOND RX, Leica Biosystems
Director, Customer Engagement, Ultivue
PHC Partnering Director, Roche Diagnostics GmbH
CTO, Turbine
Commercial Director, Oncimmune
Director GOBIOM Biomarker and Biology Services, Excelra
CTO, Insilico Medicine
Research Lecturer in Cancer Biology, PI Cancer Niche Group, Director of Blood Cancer Biobank Ireland, National University of Ireland, Galway
Director, Max Plank Institute for Molecular Genetics
Head of Diagnostics, LifeArc
Associate Principal Scientist, Science and Enabling Units IT, AstraZeneca
Senior Manager Global Regulatory Affairs, Biomarkers and Diagnostics, Merck KGaA
Director, Scientific Marketing, Metabolon
CEO, Intomics A/S
Professor of Medicine, Mayo Clinic
Co-founder and CEO, Data4Cure
Founder and CEO, Vibrent Health Inc., Principal Investigator (PI), Participant Technology Systems Center (PTSC), Co-Chair, Data Privacy and Security Work Group, Precision Medicine Initiative National Institutes of Health (NIH)
Co-founder and CEO, Pangea Diagnostics
Global Product General Manager, Early Development, Amgen, Inc
Institute of Genomics, Head of the Estonian Biobank, University of Tartu
VP, Global Head of Companion Diagnostics, AstraZeneca
Director of Business Development, Abcam
Director, Precision Medicine Policy and Business Insights, AstraZeneca
Commercial Programme Delivery Lead, Genomics England
Head of Biomarkers, Diagnostics and Assay Development, Turnstone Biologics
Director, Immunology Translational Medicine, UCB
Head Translational and Clinical Projects, Helmholtz Zentrum München
Senior Scientist Clinical Biomarker Biobanking, Merck KGaA
Senior Principal Scientist, Translational Sciences, Sanofi France
The 5th Precision Medicine & Biomarkers Leaders Summit: Europe, featuring over 30 presentations will provide experts with an exceptional environment in which to debate the key issues facing them today. The meeting focuses on strategies & technologies to deliver precision medicine, biomarkers and the progress in advancing immuno-oncology & CDx.
The potential of artificial intelligence & machine learning is explored in an extended panel discussion while another examines the strategies for successful biomarker patient selection.
NEW FOR 2018
Following the popular introduction of expert-led roundtable discussions in 2017, the number for 2018 has been doubled. Topics that will be considered include: utilizing AI for precision medicine, personalised medicine and adverse events, microbiome research for precision medicine, advancing liquid biopsy to the clinic, cardio-metabolic precision medicine and the tumour mutation burden to name just six. These take place on both days and provide an ideal opportunity for you and your peers to share and learn from each other.
Download the 2018 agendaGet news about new precision medicine and biomarker developments research and applications direct to your inbox.
Presentation by Lon Cardon, Senior Vice President, Target Sciences, GlaxoSmithKline
Presentation by Akintunde Bello, Executive Director, Bristol-Myers Squibb
Presentation by Christophe Le Tourneau, Head of Early Phase Clinical Trials & Head and Neck Cancer Groups, Institut Curie
Holiday Inn,
Munich City Centre
Hochstrasse 3,
Munich, 81669, Germany
A centrally located Munich hotel with free Wi-Fi, extensive meeting facilities and direct access to public transport.
Holiday Inn® Munich – City Centre hotel offers four-star facilities in the heart of Munich. From the Rosenheimer Platz S-Bahn station, in the same building complex, you can reach Munich Airport in 45 minutes. There is public underground parking and the city centre is a short walk away.
The Gasteig cultural centre, known for the Munich Philharmonic, is opposite the hotel, while the vast German Museum is only a five-minute walk away. Stroll to Marienplatz, the historic heart of Munich, in just 15 minutes. Visit the English Garden, two kilometres from the hotel, and Munich Residenz, a nearby Bavarian palace. In the evening try the beer gardens of Au-Haidhausen district, just seven minutes’ walk away, or ask the staff about nearby restaurants.
The hotel has one of the largest meeting centres in southern Germany. Book a function in one of 20 meeting spaces for up to 600 guests, and our friendly staff will help organise everything. There is free Wi-Fi throughout the hotel.
Enjoy a Starbucks coffee or meet colleagues for a Bavarian meal in the Open Lobby. Guests enjoy a buffet breakfast in the Grat3 restaurant with natural daylight. Executive rooms offer 180-degree city views, and kids eat and stay free.
3 for the price of 2 offer
Discount applied automatically when registering 3 places at once.
Not applicable for solution provider companies or compatible with any other offers or discount codes.
All conference sessions
Lunches and refreshments
Access to exhibition room
All networking forums
Conference workbook
e-documentation pack
Option 1 – Please phone +44 (0) 1865 84981 and we will take your details over the phone
Option 2 – Please complete the form below to pay online
Intomics was founded by leading scientists within the fields of bioinformatics and systems biology to accelerate and improve drug discovery and development through optimized usage of biomedical data.Based on vast experience with a broad range of data types and a high success rate with disease related research, the founders were convinced that the pharmaceutical industry could benefit from their pioneering research. Our focus has always been on establishing close collaborations that fully exploit the synergy between our clients’ specific disease knowledge and our unique solutions.
×Metabolon, Inc. is the world’s leading health technology company advancing metabolomics in precision medicine and life sciences research. Its Precision Metabolomics™ is a powerful technology for assessing health and delivering biomarker discoveries, innovative diagnostic tests, and valuable data for genomics and population health initiatives.
×Fluidigm is committed to empowering the cancer community with research tools for the comprehensive interrogation of immune cell function and the tumor microenvironment. Using proven mass cytometry and microfluidic technologies, we provide workflows to identify cell signatures and characterize changes in cellular phenotypes at single cell resolution.
×OncoDNA is an oncology healthcare company that combines advanced, comprehensive testing of clinically relevant cancer biomarkers (DNA, RNA and protein) from both solid and liquid biopsies with a proprietary and evolutive cancer knowledge database OncoKDO™. Based on these analysis and interpretation services for patients, OncoDNA supports biopharma partners with services ranging from cancer precision medicine data and knowledge management to NGS and molecular pathology testing lab services in clinical trial and, using the support of our oncology network we improve patient enrollment in clinical trials.
×BGI is headquartered in Shenzhen, China, with branches and medical laboratories in major cities including Beijing, Europe, North America and the Asia Pacific region. BGI has particular strengths in RNA Transcriptome for drug discovery, hereditary cancer screening, cancer immunotherapy and in aiding precision medicine research and initiatives. BGI currently operates in more than 100 countries and regions and works with more than 3000 medical institutions and more than 300 hospitals.
×Novogene is a leading provider of genomic services and solutions with cutting edge NGS and bioinformatics expertise. It is now the largest sequencing capacities in the world. Novogene utilizes scientific excellence and unsurpassed data quality to help our clients realize their research goals. With around 2,000 employees, multiple locations around the world, and over 250 publications in top tier journal, the company has recently become the world-leader in NGS services.
×Abcam is a global leader in antibody discovery and development. We specialize in producing precise biological binders to address important and novel targets in critical biological pathways. Abcam partners with pharmaceutical and diagnostic companies to develop recombinant antibodies as key reagents in drug discovery, diagnostics and therapeutics. With expertise and industry knowledge, we offer a tailored solution for end-to-end, full-cycle support of antibody commercialization: from antibody to validation support, pre-clinical selection, licensing, and market access.
×Bio-Techne® unites some of the most referenced brands in Life Sciences: R&D Systems®, Novus Biologicals®, Tocris®, ProteinSimple® and Advanced Cell Diagnostics®. Our family of brands collaborate to provide over 50,000 products for Life Science research. We have over 350,000 journal citations, showing that our combined experience is trusted by researchers. We understand our customers and we really care about their research. We want to make sure that their experiments are successful by providing reliable high performance innovative solutions for scientific discovery.
×Almac Diagnostics is a stratified medicine company specialising in biomarker driven clinical trials. Our diagnostic experience spans oncology, immunology, CNS and infective diseases. Our global laboratories, based in the UK and US offer tailored solutions from discovery to commercialisation: Biomarker discovery. Custom assay development & validation. DNA and RNA panel solutions. Flexible CDx development & commercialisation. Expert regulatory support. Bioinformatics & software development. Your Clinical Trial Diagnostic Partner.
http://www.almacgroup.com/diagnostics
×Trans-Hit Bio is the worldwide biospecimen access CRO with the most extensive collection capability for biospecimens and clinical samples through an unrivaled worldwide partnered-network of biorepositories and clinical sites, facilitating direct interactions between our customers and hospital-based-biobanks allowing the scientific-and medical expertise of academics to be drawn upon and leveraged.
×DATA4CURE’s Biomedical Intelligence® Cloud combines systems biology with an advanced semantic AI integration engine to turn big omics and clinical data into a continuously updated biomedical knowledge graph. By actively mining thousands of public and proprietary datasets and millions of biomedical publications this technology discovers genes, pathways and networks underlying disease and treatment response, merging diverse pieces of evidence to increase statistical power and facilitating continuous translation of data to knowledge. Leading pharmaceutical companies use the platform to search for new targets, repurpose drugs for new indications, identify disease subtypes and predictors of drug response and resistance.
×Precision for Medicine supports the discovery, development, clinical trial work, and implementation of biomarkers essential for targeting patients more precisely and effectively. This dynamic new field requires novel services that aren’t currently offered by traditional research organizations. We provide an uncommon array of talent and services to enable our pharmaceutical and life sciences clients to take advantage of new advancements in science and stay ahead of regulatory changes.
https://www.precisionmedicinegrp.com/pfm
×Cureline is a global precision and translational medicine CRO featuring clinical network of over a hundred clinical sites and laboratories in 18 countries and a central biorepository in the San Francisco Bay area (USA). We specialize in human sample validation project design, human biospecimens (HBS) procurement, processing and analysis, HBS management, and ex-vivo specimen laboratory treatment. Cureline supports biomarker, therapeutics and diagnostics development in Oncology, AID/inflammation, ID, metabolic and cardiovascular diseases, maternal health and other therapeutic areas. Our laboratories specialize in tissue research (IHC, FISH, and digital pathology), molecular analysis and glycoproteomics.
×Excelra is a global data-science company, empowering life science innovation. Our experience spans over 15 years in building a robust scientific data-engine powered by human and machine intelligence. We create valuable data-assets from drug chemistry to biomarkers and clinical and RWE. Excelra’s Analytics team help biopharma with customised solutions for data-driven drug discovery, drug re-purposing, systems biology and clinical trial analytics. Our proprietary databases GOSTAR (Structure-Activity Relationships), GOBIOM (Biomarkers) and CTOD (Clinical Trials Outcome) have been well received by top 20 pharma and biotech.
×Leica Biosystems (LeicaBiosystems.com) is a global leader in workflow solutions and automation, integrating each step in the workflow. As the only company to own the workflow from biopsy to diagnosis, we are uniquely positioned to break down the barriers between each of these steps. Our mission of “Advancing Cancer Diagnostics, Improving Lives” is at the heart of our corporate culture. Our easy-to-use and consistently reliable offerings help improve workflow efficiency and diagnostic confidence.
https://www.leicabiosystems.com/research/
×Biogazelle offers expert genomic services such as RNA sequencing, quantitative PCR and digital PCR under ISO 17025 accreditation or GCLP compliancy. RNA sequencing workflows are optimized for quantification of coding and non-coding (small RNA and long non-coding RNA) genes in FFPE tissue and liquid biopsies (including mRNA sequencing on plasma). Biogazelle’s RNA biomarker development program offers an end-to-end solution from RNA biomarker panel discovery to the development of a PCR-based molecular diagnostic test. Biogazelle also serves as a specialty lab in the field of clinical trials or in routine diagnostic settings.
×Our sponsorship packages offer a wide range of attendance options to suit your budget and business needs in order to maximize return on investment.
If there is any other way you would like to sponsor or increase branding for your company at the event, please get in touch and we will be able to offer you a bespoke service.
Select which delegates you would like to meet in a series of prearranged twenty-minute one-to-one meetings, held during breakout sessions from the main conference agenda. Our conference team will be available at the sessions to ensure all your meetings take place on time.
Host your own half or full day pre or post event workshop to a dedicated audience around a subject of your choice. Global Engage will assist with the marketing of your workshop to provide a guaranteed audience.
Market to our event database and / or increase brand awareness through taking a poster position or sponsoring one of the refreshment breaks, lunches, drinks receptions or poster sessions. This can be supplemented by branding options such as placing your logo on the attendee lanyards or conference bags.
Showcase your technologies and products throughout the conference in the dedicated exhibition areas where all refreshment breaks and lunches take place, as well as the networking drinks reception at the end of day one.
Options include:
For further details please contact
Tony Couch
Telephone +44 (0) 1865 849841 or
email [email protected]
Call us on +44 (0)1865 849 841
For details on attendees, packages and new opportunities, please contact our sponsorship team who will quickly provide everything you need to assess the conference for yourself.
We are a creative events marketing firm that will assist you in ensuring that your endeavours are successful. With a combination of utilizing our robust experience in the industry, professional methods, immense enthusiasm and technology, we are assisting in delivering the best service possible to our esteemed clients.
Our aim is to bring all the stakeholders in conference industry in a singular platform to help them all to get their desired outcomes. Being a boutique firm, we offer flexibility and can provide a more bespoke service to furnish your company requirements more efficiently. Our company reaches are global and our marketing leads expand over 13 promising industries ensuring the coverage of the largest target audience. Please explore the rest of our website and contact us directly for further information.
×AllSeq has created the world’s first true Sequencing Marketplace. Our NGS marketplace helps researchers pick the best provider for their needs (based on price, technology, turnaround time, etc). AllSeq also maintains the NGS Knowledge Bank, a neutral source of information on the various sequencing technologies, platforms and applications.
×American Pharmaceutical Review is a journal covering the drug pipeline from the late discovery phase through manufacturing. American Pharmaceutical Review prides itself on having the most relevant, unbiased and informative editorial in the industry. You will find that all of our editorial is highly technical and written by government agencies, consultants, academics, and large pharmaceuticals companies.
×Bentham Science Publishers is a major STM journal publisher of 130 plus print and online journal. Out of these, 39 journals have already registered good IMPACT FACTORS as per Journal Citation Reports® 2016. These titles have extensive readership mostly in Europe and North America. For a detailed profile please visit our website at http://www.benthamscience.com. Besides, Bentham Science publishes eBooks in all areas of Science, Technology and Medicine. Our eBooks provide professionals, academicians, corporate researchers, graduates and undergraduates worldwide with the most current information in their subject areas of interest. Our eBooks are also available in the ePub and Kindle formats besides the PDF edition here http://ebooks.benthamscience.com/. Bentham is offering attendees of this conference discounts on its publication. For more information click here
×Biocompare is the leading resource for up-to-date product information, product reviews, and new technologies for life scientists.
×As a network organisation, BioM supports the Bavarian biotechnology and pharmaceutical industry in establishing new business contacts on behalf of the Bavarian Ministry of Economic Affairs. BioM offers comprehensive consulting and specialized programs especially for prospective company founders.
×Global Information, Inc. is an information service company holding offices in 6 countries and have sales agency contracts with over 300 research companies around the world. We sell 30,000 market research reports published by these publishers and accept custom-made research.
×Health Europa Quarterly is a publication committed to highlighting the latest trends and developments in health and healthcare from across Europe and beyond. Our publication provides a valuable platform to the health sector, allowing them to discuss research and innovation themes, health policy and new technologies.
The accompanying website, HealthEuropa.eu, which has recently gained Google News approval, features daily news, interviews and insightful commentary from leading figures, keeping readers informed and up to date on all aspects of health and care.
×IJBHR addresses a broad range of original experimental and theoretical papers that deal with behavioural and healthcare concerns. It welcomes high-quality papers from scientists in academic and non-academic organisations as well as business and government worldwide. IJBHR is sponsored by the Business and Economics Society International and the Frontiers in Immunology Research Network.
×Functional informatics and personalised medicine in the new era of biomedical sciences and computational sciences are interactive disciplines that hold great promise for the advancement of cutting-edge research and development in biomedical informatics and pharmaceutical sciences. IJFIPM is dedicated to promoting the research, education and awareness of functional informatics and personalised medicine, and provides a common platform for the cross-fertilisation of ideas by bridging important and complementary disciplines into an interactive and attractive forum.
×The Pathologist is a must-read source for all specialists operating in the field, including molecular diagnostics, biochemistry, histology, microbiology, immunology, haematology, and cytology. Covering all aspects of the field, from research and technological breakthroughs to laboratory management and regulatory issues, The Pathologist gives a voice to the profession that is at the heart of delivering exceptional quality healthcare.
×
Pharma Journalist is a paramount B2b online magazine platform exhibiting targeted and succinct information concerning the world of Pharmaceutical Industry, therefore, keeping a tab on the updated and latest updates and trends concerning the field.
×In the realm of Pharmacy, where innovation is rapid, Pharmaceutical-Tech stands adept at conceptualizing unique ideas relevant to the B2B space. Pharmaceutical-Tech is essentially a B2B online business, technology media platform and global magazine that have under its wraps the largest global database of Pharmacy buyers and suppliers.
×Pharmalicensing (www.pharmalicensing.com) is the premier biopharmaceutical Open Innovation resource designed for professionals involved with partnering, licensing and business development worldwide.
×PharmaVOICE magazine provides readers with insightful and thought-provoking commentary about the challenges and trends impacting the life-sciences industry in a multiple-perspective format through articles covering a range of issues from molecule through market. PharmaVOICE’s more than 41,000 BPA-qualified subscribers are also kept abreast of the latest trends and information through additional media resources, including WebLinx Interactive WebSeminars, Podcasts, Videocasts, White Papers, E-Surveys and e-Alerts.
×Pink Medico – Medical and Healthcare Magazine (Print & Digital Version). We educate and empower consumers through our portal with latest news and trends, updates of medical and healthcare providers, pharma companies, new research and technologies, Medical Tourism… We are a revolutionary medical and healthcare aggregator that supports complete healthcare and allied services. We create a 360-degree approach towards quality healthcare service and ensure a wide range of people understand and avail healthcare easily. We are also NABH (National Accreditation Board for Hospitals and Healthcare Providers, India) Accredited Medical Tourism Facilitator.
×The Swiss Biotech Association (SBA) is the national industry association for biotechnology, including pharmaceuticals, diagnostics, agriculture, food, cosmetics, environmental biotechnology, and specialty chemicals. Members are companies active in modern biotechnology, such as R&D, Production, Marketing and Sales, Finance, Services and Consulting. SBA provides a networking platform for Life Science clusters, academic and federal institutions the like.
×Technology Networks is an internationally recognised, online publisher that provides access to the latest scientific news, products, research, videos and posters. Our global community is made up of over 300,000 researchers and scientific professionals from the life science, drug discovery and analytical arenas
×Sign up to receive updates, news and speaker resources
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.